Biogen MS Pill Tecfidera Gains U.S. Approval

March 27 (Bloomberg) -- Biogen Idec, the maker of multiple sclerosis drugs Avonex and Tysabri, won U.S. approvalfor its first pill for the disease, Tecfidera. Adam Johnson reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Full Show: What'd You Miss? (04/28)
51:26 - Guests include: Billionaire environmental activist Tom Steyer, Cuemacro founder Saeed Amen, Ballard Spahr's Dee Spagnuolo and Meghan Duggan, captain of the U.S. Women's National Hockey team. (Source: Bloomberg)
  • How Virtual Reality Is Impacting Storytelling
  • Quants Fire Back at Paul Tudor Jones
  • Full Show: Bloomberg Best (04/28)